New pathway to prevent fatty liver disease identified in fat tissue

Researchers have discovered that blocking a specific protein called VEGF-B in fat tissue can prevent non-alcoholic fatty liver disease from developing. The finding opens a potential new drug target for a condition affecting roughly 25% of the global population, with major implications for pharmaceutical development and healthcare costs.

Originaltitel: Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue